Introduction-In an analysis of baseline findings of an HIV incidence cohort study, an assessment was made of HIV prevalence among persons presenting for enrollment and any differences in demographic characteristics between persons not enrolled compared to those enrolled. We also described and compared HIV risk behaviors in males and females enrolled in the study.
Introduction
The search for new HIV prevention interventions, such as vaccines, microbicides, preexposure prophylaxis, and behavioral interventions, requires conducting randomized controlled clinical trials, the gold standard study design for establishing safety and efficacy for these interventions [1] . Preparation for such trials should target populations in settings of high HIV incidence or prevalence to be able to recruit persons at high risk for HIV and entails the development of the physical site, establishing cohorts of potential trial participants, building staff and laboratory capacity, and creating community awareness and engagement [2] . Experience gained during the process of preparing for cohort studies, especially measuring baseline HIV incidence, is essential to the planning and successful conduct of future trials of new prevention interventions [3] [4] .
Sub-Saharan Africa continues to be the region most heavily affected by the HIV epidemic. In 2007, the majority (69%) of adults with HIV worldwide lived in sub-Saharan Africa and 72% of AIDS deaths occurred there [4] . The 2007 Kenya AIDS Indicator Survey estimated HIV prevalence among Kenyans aged 15 to 64 years as 7.1%, and identified Nyanza Province in western Kenya as having the highest HIV prevalence (14.9%) among the eight provinces of Kenya [5] . These figures were similar to national (6.7%) and Nyanza Province (15.1%) HIV prevalence estimates among Kenyans age 15 to 49 years [5] .
Over the last decade, Kisumu, the administrative capital of Nyanza Province, has been an important location for HIV epidemiologic studies [6] and randomized controlled clinical trials of new interventions including male circumcision [7] and herpes suppression for HIV prevention among discordant couples [8] . As new effective interventions such as male circumcision are implemented and as potential changes in risk behavior may take place over time, it will be necessary to characterize the demographics and risk behavior of populations likely to be targeted for future trials of other HIV prevention interventions, and to document successful recruitment and enrollment of these individuals into HIV studies. Thus the purpose of this study is to describe characteristics of persons recruited and enrolled in an HIV vaccine preparatory cohort.
In January 2007, Kenya Medical Research Institute (KEMRI)/CDC initiated an HIV incidence cohort study to prepare for future community-based HIV vaccine (e.g., the planned Partnership for AIDS Vaccine Evaluation or PAVE 100 trial) or other prevention trials among young adults in Kisumu. The present analysis reports on the baseline findings of the cohort study which had the following primary objectives: 1) assess the prevalence of HIV among persons presenting for enrollment, and 2) determine if differences existed in demographic characteristics between persons not enrolled compared to persons enrolled. A secondary objective was to describe and compare HIV risk behaviors in males and females enrolled in the study. This paper will not report on HIV incidence or correlates of HIV infection. These findings will be presented in a separate analysis.
Methodology Study population and study site
The study was conducted in Kisumu, Nyanza Province, which has a population of approximately 500,000 residents that are predominately of Luo ethnicity [9] . The study catchment area comprised the city of Kisumu and bordering districts; a convenience sample approach was used. Criteria for participation included the following attributes: being HIV uninfected men and women (non-pregnant), 18 to 34 years of age who were sexually active within the three months prior to study enrollment and a resident of Kisumu or the surrounding area. The investigation was conducted at the study clinic of the KEMRI/CDC Clinical Research Center (CRC), which is adjacent to the New Nyanza Provincial General Hospital in Kisumu. All blood, urine, and vaginal specimens were processed and tested at the KEMRI/CDC ISO certified laboratory located at the CRC [10] .
Overall study design
We established an observational, prospective cohort beginning January 2007 that involved pre-screening, screening, enrollment and 3-monthly visits for a total of 12 months of study follow-up. Persons who tested HIV positive post enrollment were followed for an additional period of 24 months following HIV positive diagnosis.
Ethical review
The study protocol, consent forms, and data collection instruments for this study were reviewed and approved by the KEMRI local and national Scientific Steering Committees and national Ethical Review Committee as well as the United States CDC Institutional Review Board.
Community engagement and recruitment
Community engagement focused on three key activities: establishing a community advisory board (CAB); creating ongoing dialogue and fostering involvement with community stakeholders; and implementing locally appropriate as well as research feasible community mobilization approaches. The CAB was comprised of 15 individuals from key categories in the local community including chiefs, religious leaders, teachers, persons living with HIV, youth, women's groups, fishermen, local transportation, and other community-based organizations. The CAB served as a primary link between the community and the study staff. In addition to providing recommendations on how best to facilitate community awareness about the research study, the CAB advised on how to approach and negotiate interactions with influential community members, including community leaders, school heads, opinion leaders, and leaders of religious, women's and youth groups.
Recruitment occurred in multiple venues such as market centers, truck stops, beaches, churches, women's groups, community groups, formal and informal work-based groups, colleges and schools, and HIV Voluntary Counseling and Testing centers. In addition, we distributed brochures containing basic study information to potential study participants and invited interested persons to visit the study clinic for further information.
We monitored numbers of potential participants coming to the study clinic daily. Due to low enrollment of women during the first two months of the study, recruitment strategies were altered from the first-come-first-served approach used initially to a sex-based quota system to enhance recruitment of women.
Baseline screening and enrollment procedures
Pre-screening for basic eligibility, informed consent, screening and enrollment procedures were conducted at the KEMRI/CDC CRC study clinic. All data collection instruments and consent documents were available in English and translated in local languages (Kiswahili and Dholuo). Study staff was fluent in all three languages and conducted procedures in each participant's language of choice.
We performed a brief pre-screening assessment using interviewer-administered computerassisted personal interview (CAPI) to determine the first level eligibility criteria: engaged in sexual activity in last 3 months, not planning to move in next 12 months, willing to have an HIV test and receive results, not pregnant or plan to become pregnant in next 12 months, not in another HIV intervention study, never tested HIV positive, 18-34 years of age, resident of Kisumu catchment area, and willing to give locator information. Persons who met the prescreening criteria received detailed information about the study prior to providing written informed consent to proceed with screening procedures.
Screening procedures consisted of a baseline behavioral questionnaire using audio computer-assisted self-interview (ACASI); medical history; a clinical evaluation documented using CAPI; and a sample collection of blood, urine, and vaginal swabs. Male circumcision status was documented clinically. We tested for hemoglobin and platelet levels, liver and kidney function, sexually transmitted infections (STI: syphilis, HSV-2, chlamydia, gonorrhea), and pregnancy for women. Rapid HIV testing was conducted at the initial screening visit with pre-and post-test counseling.
We scheduled an appointment two weeks thereafter to deliver laboratory results and make available the final determination of study eligibility. The complete listing of study inclusion and exclusion criteria is shown in Table 1 . If eligible, individuals were enrolled at that visit, issued a study photo identification card with a barcode, and detailed locator information was obtained; this was later verified by a home visit by study staff.
Individuals who tested HIV positive at baseline screening were provided with CD4 count results and referred to HIV care and treatment clinics. All participants received monetary transport reimbursement (300KSh or about $5 US per study visit). No other monetary incentives were provided for study participation. USA). Syphilis testing was conducted using a BD Macro-Vue RPR (Rapid Plasma Reagin) card test (BD & Company, Baltimore, USA) card test and all reactive tests were confirmed by Serodia TP-PA Syphilis Test (Fujirebio Inc, Tokyo, Japan).
HSV-2 was screened using HSV-2 IgG enzyme-linked immunoassay (ELISA) and infection with Chlamydia trachomatis or Neisseriae gonorrhoeae was evaluated by qualitative polymerase chain reaction, using COBAS AMPLICOR CT/NG (Roche Diagnostics, Mannheim, Germany). Real-time parallel rapid HIV testing was conducted using Uni-Gold HIV-1/2, (Trinity Biotech, Wicklow, Ireland) and Determine HIV-1/2 (Abbott Labs, Tokyo, Japan) with Bioline (Meridian Life Science Company, Cincinnati, Ohio) used as a tiebreaker.
Analysis
To describe the sample and to compare enrolled males and females we computed frequencies, medians and Chi-square statistics. Because expected cell counts for some variables dropped below 5, we used Fisher's exact test for all comparisons. A Wilcoxon test was used for continuous variables. In addition, we conducted bivariate and multiple regression analyses to determine demographic variables associated with being enrolled in the study or not. All demographic variables, regardless of their significance in bivariate analysis, were entered into the multiple logistic regression model. For HIV prevalence estimates, we calculated rates overall and by age and gender strata. Confidence intervals for these estimates were based on the binomial distribution.
Results
Between March 2007 and March 2008, a total of 1,277 individuals were prescreened for basic study eligibility, of whom 867 (68%) met preliminary criteria (Figure 1 ). Among the 410 (32%) individuals initially excluded, reasons for the exclusions included sexual inactivity (n = 290, 70.7%), intention to move away from Kisumu (n = 139, 33.9%), intention to become pregnant (n = 61, 14.9%), and unwillingness to undergo HIV testing [n = 66 (38 male + 28 female; p = NS), 16 .1%] or receive HIV test results [n = 59 (39 male + 20 females; p = 0.10), 14.4%]. A few were excluded for other reasons such as current enrollment in an HIV intervention study (n = 29, 7.1%), previously tested HIV positive (n = 16, 3.9%), unwillingness to come for study visits (n = 16, 3.9%) and current pregnancy (n = 15, 3.7%). Among the 846 who met the criteria and completed the screening, 625 (48.9% of those recruited) were enrolled; 189 were not eligible after completing the ACASI questionnaire and laboratory testing. See Figure 1 for additional details regarding baseline screening and enrollment.
HIV prevalence among individuals presenting for enrollment
Among those who completed screening, overall HIV prevalence was 14.8% (125/846); 21.5% among females (91/424) and 8.1% among males (34/422). Prevalence was significantly higher among females than males overall and in all age groups with the exception of the 30 to 34 years age group (Table 2 ). In addition, there was a significant difference in overall HIV prevalence among the three age groups (χ 2 (2) = 29.2; p < 0.001). Pairwise comparisons showed that the 25 to 29 years (χ 2 (1) = 10.8; p < 0.001) and the 30 to 34 years age groups (χ 2 (1) =24.8; p <0.001) had higher prevalence than the 18 to 24 years age group.
Enrolled compared to non-enrolled individuals: demographic characteristics
Differences were found in some demographic characteristics between enrolled and not enrolled persons, specifically in terms of age, gender, marital status, education, language preference, and migration history (Table 3) 
Enrolled compared to non-enrolled individuals: motivation for participation, male circumcision, HIV and STIs
A lower proportion of persons enrolled versus not enrolled reported their primary motivation for participation was due to incentives provided by the study (p = 0.015), tested positive for HSV-2 (p < 0.001), gonorrhea (p = 0.014) and syphilis (p = 0.008). There was no significant difference in male circumcision or chlamydia (Table 3 ). All persons enrolled had to be HIV-1 negative.
Enrolled males compared to enrolled females: sexual behaviors and other HIV risk behaviors
Overall, the most prevalent HIV risk behaviors were unprotected sex (49%), alcohol use (45%), and transactional sex (30%) in last the three months (Table 4) . Compared to females, a greater proportion of males reported using any alcohol (p < 0.001) or any drug in the last three months (p < 0.001), a history of oral sex (p = 0.032), sex with partner other than a spouse or main partner in the last three months (p < 0.001), ever having a blood transfusion (p = 0.009), had an HIV test prior to screening (p < 0.042), and having knowledge of their last HIV test result (p = 0.016) ( Table 4) . Men also reported a younger age at sexual debut (p < 0.001), a greater number of lifetime partners (p < 0.001), a greater number of opposite sex partners in the last three months (p < 0.001), and also a greater number of times ever tested for an STI and number of lifetime HIV tests (p < 0.001).
Discussion
Our analysis demonstrated the successful recruitment of young adults to assess HIV incidence and to prepare for future HIV prevention studies in this high HIV prevalence region of western Kenya. [12] . In these studies, as in many previous studies [5, 13] , we found a higher HIV prevalence among females than males, and increasing prevalence with increasing age emphasizing the disproportionate burden of disease among girls and women in sub-Saharan Africa [14] .
In contrast to other similar studies, our analysis assessed differences between individuals enrolled and those not enrolled. While there were many similarities between these two groups, there were a few differences. The odds of being enrolled were higher for younger (18 to 24 years) compared to older persons and for men compared to women, and lower for persons who chose Dholuo for their ACASI language. That the enrolled group was younger and predominantly male represents the epidemiology of the epidemic in this population of western Kenya, specifically in that older individuals and females are more likely to be infected [11, 12, 15] . Our ability to enroll younger persons prior to HIV infection, however, is desirable for implementation of future HIV prevention trials in this population.
The difference in language preference for ACASI may be attributed to the higher proportion of people speaking English in the urban area where the study was conducted as compared to Dholuo being preferred more in the rural areas. Two additional results are worth noting. First, among all men screened, 46% were circumcised as determined by clinical examination. This is more than the 27.5% reported almost a decade earlier [16] and is expected considering the results of a study conducted in Kisumu, showing the protective effects of male circumcision for HIV infection [7] . Second, among individuals presenting for enrollment in our study, about 30% were excluded because they did not want an HIV test or did not want to know their results, perhaps due to concerns about potential negative social repercussions of being HIV infected, which has been reported in other studies [11, 17] . Hopefully these fears of stigmatization will decrease with greater access to HIV treatment and other services in recent years so that HIV will be considered more of a chronic disease.
We also confirmed gender differences in sexual behaviors and other HIV risk behaviors that have been reported previously [13, 18] . In addition to reporting an earlier age at sexual debut and a greater number of partners than women, men more frequently reported such risk behaviors as using alcohol, using recreational drugs, having sex with a partner other than a spouse or main partner, and having ever been treated for an STI. Problem alcohol drinking has been reported to be higher among men than women [19] . In addition, having sex while intoxicated has been associated with high risk of sexual behaviors such as unprotected sex with casual partners and paying for sex [20] . The 2000-2001 UNAIDS prevention campaign, titled "Men Make a Difference", attempted to address this issue and worked to motivate men and women to communicate about HIV risk behaviors such as alcohol and drug use and to encourage men to care for themselves and their partners and families [21] .
The higher HIV prevalence among women not eligible for enrollment is likely due to multiple factors including HIV transmission being more efficient from infected men to uninfected women [22] , young girls having sex with older men in exchange for gifts or favors [23] , early marriage of adolescent girls which can lead to other health problems through early pregnancy [24] , and the loss of educational opportunities [13, 25, 26] . Education is an effective means of HIV prevention in that it equips children to make informed decisions about their own health and at the same time contributes to the empowerment and economic independence of girls and women [27] . Other gender differences, such as unwanted or forced sex can be explained by the subordinate position of women in the society where many girls and women lack not only resources, but the ability to obtain resources, the ability to obtain leadership positions, and the power to make decisions [15, 28] . It is noteworthy that there was no significant difference between men and women in the proportion reporting receiving food, shelter, money, gifts or other favors for sex in the last three months given that a key HIV risk factor in the literature is payment to girls and women for sex (e.g., Sugar Daddy) [29] [30] [31] . The literature is sparse regarding payment to boys/men for sex ("Sugar Mummies"), but gifts or favors from girls to boys has been reported as part of the dating ritual [30] .
Our analysis findings should be interpreted in light of at least two potential limitations. First, our research participants were self-selected and may not be representative of the Kisumu population. Second, there may be response bias as with all surveys although we believe use of ACASI facilitated more honest responding [32] . The strength of our analysis, however, is that it provided information on both participants enrolled in the study and individuals who were not enrolled and the reasons that they were not enrolled.
In conclusion, in an area of Kenya with very high HIV prevalence, we successfully enrolled persons with HIV risk characteristics in an HIV incidence cohort. Overall, the enrolled and not enrolled groups were comparable with a few exceptions such as differences in age and gender. Gender-related differences in sexual behaviors and other HIV risk behaviors were similar to those previously reported in Kenya. Notably, females had higher HIV prevalence (21.5% versus 8.1%). This finding underscores the importance of focusing on adolescent girls and women to combat the HIV epidemic [33, 34] via biomedical interventions such as microbicides [35] and/or structural/policy interventions such as education [36] which would provide girls with increased access to HIV knowledge, economic resources, and decisionmaking power [37] . Meet the following laboratory criteria: serum creatinine < 1.5mg/dl, haemoglobin ≥ 9.0g/dl, platelets > 50,000/ml, ALT < 2.5 times the upper limit of normal
Willing to comply with study procedures and requirements if meet criteria for study eligibility
Exclusion criteria

HIV seropositive
Pregnant or plan to become pregnant in next 12 months if female
Plan to reside outside the Kisumu catchment area for >3 months
Evidence of clinically significant cardiac, respiratory, hepatic, gastrointestinal, endocrine, hematologic, psychiatric, neurologic, or allergic disease that would compromise the ability of the participant to provide competent informed consent, or to complete study procedures or study requirements as determined by the principal investigator or designated associate.
The clinical significance of any abnormality is to be evaluated in the context of the safety of the patient volunteer and the objectives of this study.
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